Comparing EUDA Health (NASDAQ:EUDA) & Outset Medical (NASDAQ:OM)

Outset Medical (NASDAQ:OM) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations.

Insider & Institutional Ownership

4.4% of EUDA Health shares are held by institutional investors. 2.4% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Outset Medical and EUDA Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Outset Medical	-68.34%	-55.65%	-28.64%
EUDA Health	N/A	N/A	N/A

Earnings and Valuation

This table compares Outset Medical and EUDA Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48 million	0.70	-$81.65 million	($6.79)	-0.67
EUDA Health	$4.01 million	7.20	-$15.36 million	($2.40)	-4.78

EUDA Health has lower revenue, but higher earnings than Outset Medical. EUDA Health is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Outset Medical has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Comparatively, EUDA Health has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Outset Medical and EUDA Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1	1	2	1	2.60
EUDA Health	2	0	1	0	1.67

Outset Medical presently has a consensus price target of $10.00, indicating a potential upside of 118.82%. EUDA Health has a consensus price target of $55.00, indicating a potential upside of 379.93%. Given EUDA Health’s higher probable upside, analysts plainly believe EUDA Health is more favorable than Outset Medical.

Summary

EUDA Health beats Outset Medical on 8 of the 15 factors compared between the two stocks.

About Outset Medical

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

About EUDA Health

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.